- cafead   Jul 11, 2022 at 06:12: PM
via Dr. Reddy's Laboratories is gunning for Pfizer’s extended-release overactive bladder treatment Toviaz, introducing a therapeutic generic equivalent that could threaten more than $200 million in revenues.
article source
article source